Terns Pharmaceuticals, Inc. (TERN)

Last Closing Price: 29.36 (2025-12-05)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Terns Pharmaceuticals, Inc. (TERN) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
--
$-24.64M
Cost of Goods Sold
--
--
$27.72M
$-27.72M
$3.13M
$-24.59M
$-24.59M
$-24.64M
$-24.64M
$-24.64M
$-24.64M
$-27.72M
$-27.47M
91.70M
91.70M
$-0.27
$-0.27
Balance Sheet Financials
$300.30M
$0.06M
$1.36M
$301.65M
$15.39M
--
$2.20M
$17.59M
$284.07M
$284.07M
$284.07M
87.51M
Cash Flow Statement Financials
$-63.09M
$51.96M
$0.39M
$161.44M
$150.70M
$-10.74M
$10.05M
--
--
Fundamental Metrics & Ratios
19.52
--
--
--
--
--
--
--
--
--
--
$-63.09M
--
--
--
--
--
--
--
-8.67%
-8.67%
-8.17%
-8.67%
$3.25
$-0.69
$-0.69